have shown that highly expressed FTO can inhibit the immune activity of T lymphocytes by increasing the expression of the immunosuppressive checkpoint molecule/gene “LILRB4”, thereby promoting the progression of leukemia stem cells. Here, FTO is linked to leukemia.